Context Therapeutics
Price & Volume
Stats
See more52W Range | $0.55-$2.75 |
Market Cap | $89.7M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.46 |
News
See moreYahoo Finance • 29 days ago
Context Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • last month
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025
Yahoo Finance • last month
Context Therapeutics Reports Full Year 2024 Operating and Financial Results
Yahoo Finance • 2 months ago
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Martin A. Lehr |
CFO | Ms. Jennifer Minai-Azary |
Address | 2001 Market Street, Philadelphia, PA, United States, 19103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
